← Back to directory
Not currently recruitingFunding unknown
- Works count
- 77
- Citation count
- 4,966
- H-index
- 19
- i10-index
- 23
Research interests
Medicine
HER2/EGFR in Cancer Research
Advanced Breast Cancer Therapies
Cancer Immunotherapy and Biomarkers
Prostate Cancer Treatment and Research
PARP inhibition in cancer therapy
Publications
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
New England Journal of Medicine · 2024 · 10.1056/nejmoa2403614
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet · 2015 · 10.1016/s0140-6736(15)00986-1
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70189-5
Current projects
No projects listed.